...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Hypothetical:  Lets say cencora pulls a rabbit out of the hat.  What would be a good estimate of the pps in an outright sale and/or CVR?  How many shares exist, fully diluted?

Share
New Message
Please login to post a reply